These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9820472)

  • 1. Hyperlipidemia in patients with chronic renal disease.
    Kasiske BL
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S142-56. PubMed ID: 9820472
    [No Abstract]   [Full Text] [Related]  

  • 2. Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patients.
    Fox CS; Longenecker JC; Powe NR; Klag MJ; Fink NE; Parekh R; Coresh J;
    Clin Nephrol; 2004 May; 61(5):299-307. PubMed ID: 15182124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and Renal Disease.
    Shah A; Olivero JJ
    Methodist Debakey Cardiovasc J; 2019; 15(1):88-89. PubMed ID: 31049156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management.
    Saland JM; Ginsberg H; Fisher EA
    Curr Opin Pediatr; 2002 Apr; 14(2):197-204. PubMed ID: 11981290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular disease and the renal transplant recipient.
    Kendrick E
    Am J Kidney Dis; 2001 Dec; 38(6 Suppl 6):S36-43. PubMed ID: 11729004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk reduction in renal transplantation. Strategies for success.
    Kiberd BA
    Minerva Urol Nefrol; 2002 Jun; 54(2):51-63. PubMed ID: 12070454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should hyperlipidaemia in dialysis patients be treated?
    Wheeler DC
    Nephrol Dial Transplant; 1997 Jan; 12(1):19-21. PubMed ID: 9027766
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S112-9. PubMed ID: 9820470
    [No Abstract]   [Full Text] [Related]  

  • 10. Dyslipidemia treatment and cardiovascular disease in the renal patient.
    Burst V; Benzing T
    Curr Pharm Des; 2011; 17(9):894-907. PubMed ID: 21418028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of hyperlipidaemia and therapy in renal patients.
    Wanner C
    Nephrol Dial Transplant; 2000; 15 Suppl 5():92-6. PubMed ID: 11073280
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischaemic heart disease, lipids and the kidney.
    Brown JH; Short CD; Mallick NP
    Contrib Nephrol; 1993; 102():198-219. PubMed ID: 8416183
    [No Abstract]   [Full Text] [Related]  

  • 14. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States.
    Collins AJ; Kasiske B; Herzog C; Chen SC; Everson S; Constantini E; Grimm R; McBean M; Xue J; Chavers B; Matas A; Manning W; Louis T; Pan W; Liu J; Li S; Roberts T; Dalleska F; Snyder J; Ebben J; Frazier E; Sheets D; Johnson R; Li S; Dunning S; Berrini D; Guo H; Solid C; Arko C; Daniels F; Wang X; Forrest B; Gilbertson D; St Peter W; Frederick P; Eggers P; Agodoa L
    Am J Kidney Dis; 2003 Dec; 42(6 Suppl 5):A5-7, S1-230. PubMed ID: 14655179
    [No Abstract]   [Full Text] [Related]  

  • 15. Is peritoneal dialysis associated with increased cardiovascular morbidity and mortality?
    Van Biesen W; Vanholder R; Verbeke F; Lameire N
    Perit Dial Int; 2006; 26(4):429-34. PubMed ID: 16881336
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal insufficiency is an important cardiovascular risk factor].
    Pérez Flores I; Luño J
    Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of hyperlipidemia in patients on peritoneal dialysis: current approaches.
    Prichard SS
    Kidney Int Suppl; 2006 Nov; (103):S115-7. PubMed ID: 17080100
    [No Abstract]   [Full Text] [Related]  

  • 19. A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease.
    Albakr RB; Bargman JM
    Cardiol Clin; 2021 Aug; 39(3):447-453. PubMed ID: 34247757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension in patients with chronic renal disease.
    Mailloux LU; Levey AS
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S120-41. PubMed ID: 9820471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.